News
Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...
Eli Lilly is tagging along on actress Kym Whitley’s blockbuster summer in a fresh Zepbound partnership with the “Happy ...
David Mooney, who most recently served as Chief of Cyber Protective Services at the Cybersecurity and Infrastructure Security ...
12hon MSN
Penn's Kiran Musunuru spoke with The Inquirer about the future of CRISPR technology.
Eli Lilly and Company (NYSE:LLY) is one of the high-margin pharma stocks to buy now. Eli Lilly and Company (NYSE:LLY) is set ...
Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...
Caitlin Clark added another Prada entry to her growing off-court fashion record, this time stepping into sculptural ivory ...
The opportunity to “ talk to a doctor now ” increases access to care, the drug companies say. But the legislators, and some ...
Eli Lilly's weight loss drugs, especially Zepbound and Mounjaro, have driven impressive revenue growth. Click here to read an ...
Lilly Endowment Community Scholarship application will open through the Johnson County Community Foundation on Aug. 1.
After a nine-month investigation into direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer, a group of ...
Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results